An Update on Treatment and Management of Pediatric Systemic Lupus Erythematosus

被引：27

作者：

Thakral A. ^{[1
]}

Klein-Gitelman M.S. ^{[1
,2
]}

机构：

[1] Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University, Chicago, IL

[2] Feinberg School of Medicine, Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University, Chicago, IL

来源：

Rheumatology and Therapy | 2016年 / 3卷 / 2期

关键词：

Autoimmune; Management; Medication; Pediatric; Rheumatology; Systemic lupus erythematosus; Treatment;

D O I：

10.1007/s40744-016-0044-0

中图分类号：

学科分类号：

摘要：

Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disorder in which 20 % of patients are diagnosed in childhood. Childhood-onset SLE is associated with higher morbidity and mortality than adult-onset SLE. The aims of disease management with early immunosuppression are to decrease disease activity and improve quality of life. A multidisciplinary approach is necessary due to the complexity of lupus in pediatric patients. It is important to provide patients with high quality of care and to instill ownership of their disease process from a young age to prepare them to manage this life-long illness. This article reviews current management of SLE in children. © 2016, The Author(s).

引用

页码：209 / 219

页数：10

共 43 条

[1]

Barsalou J., Levy D.M., Silverman E.D., An update on childhood-onset systemic lupus erythematosus, Curr Opin Rheumatol, 25, 5, pp. 616-622, (2013)

[2]

Brunner H.I., Huggins J., Klein-Gitelman M.S., Pediatric SLE—towards a comprehensive management plan, Nat Rev Rheumatol, 7, 4, pp. 225-233, (2011)

[3]

Hollander M.C., Sage J.M., Greenler A.J., Pendl J., Avcin T., Espada G., Et al., International consensus for provisions of quality-driven care in childhood-onset systemic lupus erythematosus, Arthritis Care Res, 65, 9, pp. 1416-1423, (2013)

[4]

Hochberg M.C., Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 40, 9, (1997)

[5]

Petri M., Orbai A.M., Alarcon G.S., Gordon C., Merrill J.T., Fortin P.R., Et al., Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus, Arthritis Rheum, 64, 8, pp. 2677-2686, (2012)

[6]

Sag E., Tartaglione A., Batu E.D., Ravelli A., Khalil S.M., Marks S.D., Et al., Performance of the new SLICC classification criteria in childhood systemic lupus erythematosus: a multicentre study, Clin Exp Rheumatol, 32, 3, pp. 440-444, (2014)

[7]

Hersh A.O., Trupin L., Yazdany J., Panopalis P., Julian L., Katz P., Et al., Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus, Arthritis Care Res, 62, 8, pp. 1152-1159, (2010)

[8]

Guiducci C., Gong M., Xu Z., Gill M., Chaussabel D., Meeker T., Et al., TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus, Nature, 465, 7300, pp. 937-941, (2010)

[9]

Mina R., von Scheven E., Ardoin S.P., Eberhard B.A., Punaro M., Ilowite N., Et al., Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus, Arthritis Care Res, 64, 3, pp. 375-383, (2012)

[10]

Kasturi S., Sammaritano L.R., Corticosteroids in lupus, Rheum Dis Clin N Am, 42, 1, pp. 47-62, (2016)

← 1 2 3 4 5 →